Sign in

CIK 0001593899

  • Non-accelerated filer
  • Smaller reporting company

Atea Pharmaceuticals, Inc.

Sign in to watch
Ticker
AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
460574869
Phone
+1 857-284-8891
Business address
225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$168,095
in 1 filing

Net −$168,095. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Polsky Bruce −$168K Director sold 21% of stake
Date Insider Transaction Shares Price Value Owned after
2025-06-20 Duncan Barbara Gayle Director Exercise or conversion +29,600 62,750
2025-06-20 Duncan Barbara Gayle Director Grant or award · Restricted Stock Units +29,600 29,600
2025-06-20 Duncan Barbara Gayle Director Grant or award · Stock Option (Right to Buy) +41,200 41,200
2025-06-20 Duncan Barbara Gayle Director Exercise or conversion · Restricted Stock Units −29,600 0
2024-06-21 Duncan Barbara Gayle Director Grant or award · Restricted Stock Units +29,600 29,600
2024-06-21 Duncan Barbara Gayle Director Grant or award · Stock Option (Right to Buy) +41,200 41,200
2024-06-16 Duncan Barbara Gayle Director Exercise or conversion +33,150 33,150
2024-06-16 Duncan Barbara Gayle Director Exercise or conversion · Restricted Stock Units −33,150 0
2023-06-16 Duncan Barbara Gayle Director Grant or award · Restricted Stock Units +33,150 33,150
2023-06-16 Duncan Barbara Gayle Director Grant or award · Stock Option (Right to Buy) +46,750 46,750
2022-06-17 Duncan Barbara Gayle Director Grant or award · Stock Option (Right to Buy) +61,264 61,264
2021-06-18 Duncan Barbara Gayle Director Grant or award · Stock Option (Right to Buy) +34,025 34,025
2020-10-29 Duncan Barbara Gayle Director Grant or award · Stock Option (Right to Buy) +80,000 80,000

Page 1 of 1 · 13 trades